The artificial cornea and corneal implant market is a rapidly advancing segment of ophthalmology, aimed at addressing the rising prevalence of corneal blindness and associated conditions. While corneal transplantation remains the standard treatment, limitations such as donor shortages and transplant rejection have spurre